71 related articles for article (PubMed ID: 15872368)
21. The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
De Klerk JM; Oyen WJ
Minerva Endocrinol; 2009 Mar; 34(1):57-69. PubMed ID: 19209128
[TBL] [Abstract][Full Text] [Related]
22. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
Kalinyak JE; McDougall IR
Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
[No Abstract] [Full Text] [Related]
23. Thyroid stunning in clinical practice: is it a real problem?
Filesi M; Colandrea M; Montesano T; D'Apollo R; Ronga G
Minerva Endocrinol; 2009 Mar; 34(1):29-36. PubMed ID: 19209126
[TBL] [Abstract][Full Text] [Related]
24. Initial radioiodine administration: when to use it and how to select the dose.
Esposito G
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
[TBL] [Abstract][Full Text] [Related]
25. Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.
Salvatori M; Luster M
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):821-8. PubMed ID: 20186542
[No Abstract] [Full Text] [Related]
26. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
Lassmann M; Reiners C; Luster M
Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
[TBL] [Abstract][Full Text] [Related]
27. [The effect of ionizing radiation on the thyroid].
Gerasimov GA
Probl Endokrinol (Mosk); 1991; 37(4):64-7. PubMed ID: 1788197
[No Abstract] [Full Text] [Related]
28. The use of dosimetry in the treatment of differentiated thyroid cancer.
Lassmann M; Hänscheid H; Verburg FA; Luster M
Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):107-15. PubMed ID: 21386785
[TBL] [Abstract][Full Text] [Related]
29. [Main trends and controversies in treatment of patients with diffuse toxic goiter and thyroid gland cancer].
Romanchishen AF; Vabalaĭte KV
Vestn Khir Im I I Grek; 2011; 170(3):58-63. PubMed ID: 21848241
[No Abstract] [Full Text] [Related]
30. [Thyroid and radiation].
Yamashita S; Namba H; Nagataki S
Nihon Naibunpi Gakkai Zasshi; 1993 Nov; 69(10):1035-43. PubMed ID: 8282128
[TBL] [Abstract][Full Text] [Related]
31. Radioactive iodine (131I) effects on male fertility.
Ceccarelli C; Canale D; Vitti P
Curr Opin Urol; 2008 Nov; 18(6):598-601. PubMed ID: 18832945
[TBL] [Abstract][Full Text] [Related]
32. Effects of radiation on the thyroid gland.
Van Middlesworth L
Adv Intern Med; 1989; 34():265-84. PubMed ID: 2644760
[No Abstract] [Full Text] [Related]
33. The effects of radiation on the thyroid gland: a quantitative analysis.
Rall JE
Prog Clin Biol Res; 1981; 74():29-43. PubMed ID: 7033984
[TBL] [Abstract][Full Text] [Related]
34. [Cytogenetic control in exposure to ionizing radiation sources (review of literature)].
Nugis VIu
Med Tr Prom Ekol; 2006; (10):30-6. PubMed ID: 17136843
[No Abstract] [Full Text] [Related]
35. Thyroid stunning: fact or fiction?
McDougall IR; Iagaru A
Semin Nucl Med; 2011 Mar; 41(2):105-12. PubMed ID: 21272684
[TBL] [Abstract][Full Text] [Related]
36. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma.
Fard-Esfahani A; Emami-Ardekani A; Fallahi B; Fard-Esfahani P; Beiki D; Hassanzadeh-Rad A; Eftekhari M
Nucl Med Commun; 2014 Aug; 35(8):808-17. PubMed ID: 24751702
[TBL] [Abstract][Full Text] [Related]
37. Iodine isotopes in radiation hygiene.
Vasilenko IY
J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):142-9. PubMed ID: 6997372
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.
Sgouros G; Hobbs RF; Atkins FB; Van Nostrand D; Ladenson PW; Wahl RL
Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1(Suppl 1):S41-7. PubMed ID: 21484384
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of toxicological hazards from medical radioiodine administration.
Van Dyke M; Punja M; Hall MJ; Kazzi Z
J Med Toxicol; 2015 Mar; 11(1):96-101. PubMed ID: 25008160
[No Abstract] [Full Text] [Related]
40. Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer.
Van Nostrand D
Oral Dis; 2011 Mar; 17(2):154-61. PubMed ID: 21029259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
